Company: FCRX
Filing Date: 2025-02-03
Form Type: N-2/A
Source: 0001193125-25-018583
Chunk: 72

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-02-03
Form: N-2/A
Chunk 72
---
 the price at which and the currency or currencies, including composite currencies, in which these shares may be purchased upon such exercise; |

| • |     | the date on which the right to exercise such warrants shall commence and the date on which such right will expire; |

| • |     | whether such warrants will be issued in registered form or bearer form; |

| • |     | if applicable, the minimum or maximum amount of such warrants that may be exercised at any one time; |

| • |     | if applicable, the date on and after which such warrants and the related securities will be separately transferable; |

| • |     | information with respect to book-entry procedures, if any; |

| • |     | the terms of the securities issuable upon exercise of the warrants; |

| • |     | if applicable, a discussion of certain U.S. federal income tax considerations; and |

| • |     | any other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants. |

79

We and the warrant agent may amend or supplement the warrant agreement for a series of warrants without the consent of the holders of the warrants issued thereunder to effect changes that are not inconsistent with the provisions of the warrants and that do not materially and adversely affect the interests of the holders of the warrants. Prior to exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including, in the case of warrants to purchase debt securities, the right to receive principal, premium, if any, or interest payments, on the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture or, in the case of warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up or to exercise any voting rights. Under the 1940 Act, we may generally only offer warrants provided that (a) the warrants expire by their terms within ten years, (b) the exercise or conversion price is not less than the current market value at the date of issuance, (c) our stockholders authorize the proposal to issue such warrants, and our Board approves such issuance on the basis that the issuance is in the best interests of Crescent Capital and its stockholders and (d) if the warrants are accompanied by other securities, the warrants are not separately transferable unless no class of such warrants and the securities accompanying them has been